Skip to Content
Merck
All Photos(1)

Key Documents

View All Documentation

262412

Sigma-Aldrich

4-(Butylamino)benzoic acid

97%, for peptide synthesis

Synonym(s):

p-Butylaminobenzoic acid

Sign Into View Organizational & Contract Pricing
All Photos(1)

About This Item

Linear Formula:
CH3(CH2)3NHC6H4CO2H
CAS Number:
4740-24-3
Molecular Weight:
193.24
MDL number:
MFCD00002536
UNSPSC Code:
12352106
eCl@ss:
32160406
PubChem Substance ID:
24855739
NACRES:
NA.22

product name

4-(Butylamino)benzoic acid, 97%

Quality Level

100

Assay

97%

form

powder

reaction suitability

reaction type: solution phase peptide synthesis

mp

149-151 °C (lit.)

application(s)

peptide synthesis

SMILES string

CCCCNc1ccc(cc1)C(O)=O

InChI

1S/C11H15NO2/c1-2-3-8-12-10-6-4-9(5-7-10)11(13)14/h4-7,12H,2-3,8H2,1H3,(H,13,14)

InChI key

YCCRFDDXAVMSLM-UHFFFAOYSA-N

Looking for similar products? Visit Product Comparison Guide

Pictograms

Exclamation mark
GHS07

Signal Word

Warning

Hazard Statements

H315,H319,H335

Hazard Classifications

Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3

Target Organs

Respiratory system

Storage Class Code

11 - Combustible Solids

WGK

WGK 3

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Personal Protective Equipment

dust mask type N95 (US), Eyeshields, Gloves

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
MKCM3393
MKCF4051
MKBS0590V
MKBQ0242V
MKBH8566V

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Miranda de Jager et al.
Pharmaceutical research, 23(5), 951-960 (2006-05-23)
The objective of this study was to evaluate the utility of a stratum corneum substitute (SCS) as a novel in vitro percutaneous penetration model. The SCS consists of synthetic stratum corneum (SC) lipids (cholesterol, free fatty acids, and specific ceramides)
K Kudo et al.
Forensic science international, 116(1), 9-14 (2000-12-19)
Blood concentrations of tetracaine and its metabolite, p-butylaminobenzoic acid, were measured after spinal anesthesia with tetracaine which had been administered to patients under going orthopedic surgery. Tetracaine, an ester anesthetic, was given to 10 patients, the dose was 8-14mg, and
R Murtaza et al.
Journal of pharmacological and toxicological methods, 46(3), 131-136 (2002-08-17)
The purpose of the present study was to develop a simple method for the simultaneous determination of mepivacaine, tetracaine, and p-butylaminobenzoic acid (BABA) in human plasma using high-performance liquid chromatography (HPLC) with a multiwavelength detector. Human blood samples containing heparin
G N Menon et al.
Journal of pharmaceutical sciences, 70(5), 569-570 (1981-05-01)
A high-performance liquid chromatographic method was developed for the simultaneous determination of tetracaine hydrochloride and its hydrolytic degradation product, p-n-butylaminobenzoic acid. Separation was achieved using a mu Bondapak C18 column and the eluent, water-acetonitrile-methanol (60:20:20), containing 0.06% (v/v) sulfuric acid
Simultaneous determination of chlorhexidine, tetracaine and their degradation products by ion-pair liquid chromatography.
M Bauer et al.
Journal of chromatography, 315, 457-464 (1984-12-19)

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service